German generics maker Stada is plunking down 56 million euro ($76.6 million) for the U.K. pharma group Forum Bioscience. Antitrust regulators will have to bless the deal. Report
German generics maker Stada is plunking down 56 million euro ($76.6 million) for the U.K. pharma group Forum Bioscience. Antitrust regulators will have to bless the deal. Report